Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Isbell H |
Effects of various drugs on the LSD reaction |
Psychopharmacology F... |
1959 |
Weckowicz TE |
The effect of lysergic acid diethylamide (LSD) on size constancy |
Canad. psychiat. Ass... |
1959 |
LE Hollister, JJ Prusmack... |
Comparison of three psychotropic drugs (Psilocybin, JB-329, and IT-290... |
J. Nerv. & Ment. Dis... |
1960 |
Sercl M, Lovarik J, Jaros... |
Klinische Erfahrungen mit Psilocybin (CY 39 Sandoz) |
Psychiatria et Neuro... |
1961 |
M Sercl, J Kovarik, O Jar... |
Klinische Erfahrungen mit psilocybin (CY 39 Sandoz) |
Psych. Neuro. |
1961 |
Touyaa HJ |
Resultados de nuestro trabajo clinico |
Psicoterapia con alu... |
1965 |
Nielsen J, Friedrich U, T... |
Chromosome abnormalities and psychotropic drugs |
Nature |
1968 |
Barr HL, Langs RJ, Holt R... |
LSD : Personality And Experience |
|
1972 |
Fernandez J, Browne IW, C... |
LSD...an in vivo retrospective chromosome study. |
Annals of Human Gene... |
1973 |
Fossati C |
I Danni Provocati Dall'abuso di Bevande Alcooliche: Possibilita di Dis... |
Clin Ter |
1974 |
Siva Sankar DV |
LSD-a Total Study |
|
1975 |
Drummond AH, Gordon JL |
Inhibition of 5-Hydroxy-(3H)-tryptamine Binding to Rat Blood Platelets... |
Brit.J.Pharmacol. |
1975 |
Klock JC, Boerner U, Beck... |
Coma, Hyperthermia, and Bleeding Associated with Massive LSD Overdose,... |
Clinical Toxicology |
1975 |
Belanger M, Chibon P, Cou... |
Etude radiologique des effets du LSD-25 sur l'amphibien pleurodeles wa... |
Compt.Rend.Soc.Biol. |
1976 |
Bethel RG |
Abuse of Asthma Cigarettes |
Br Med J |
1978 |
Sloviter RS, Drust EG, Da... |
Serotonergic Mediation Of Behavioral Effects In Rats Of Indoles And Ph... |
Federation Proc. |
1980 |
Young RE, Milroy R, Hutch... |
The Rising Price Of Mushrooms |
The Lancet |
1982 |
Monroe PJ, Smith DJ |
Characterization of Multiple [3H]5-Hydroxytryptamine Binding Sites in ... |
J. Neurochem. |
1983 |
Waehtel H, Dorow R |
Dual Action On Central Dopamine Function Of Transdihydrolisuride, A 9,... |
Life Sciences |
1983 |
Mathews JD, Riley MD, Fej... |
Effects of the heavy usage of kava on physical health: summary of a pi... |
Med J Aust |
1988 |
Appel JB, Callahan PM |
Involvement of 5-HT receptor subtypes in the discriminative stimulus p... |
Eur J Pharmacol |
1989 |
Schmidt CJ, Abbate GM, Bl... |
Selective 5-hydroxytryptamine2 receptor antagonists protect against th... |
J Pharmacol Exp Ther |
1990 |
Garrett ER, Seyda K, Marr... |
High performance liquid chromatographic assays of the illicit designer... |
Acta Pharm Nord |
1991 |
Glennon RA |
MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethy... |
Pharmacol Biochem Be... |
1993 |
Cuomo MJ, Dyment PG, Gamm... |
Increasing Use of 'Ecstasy' (MDMA) and Other Hallucinogens on a Colleg... |
J Am Coll Health |
1994 |
Shen M, Piser TM, Seybold... |
Cannabinoid receptor agonists inhibit glutamatergic synaptic transmiss... |
J Neurosci |
1996 |
Nakahara Y, Kikura R, Tak... |
Detection of LSD and metabolite in rat hair and human hair |
J Anal Toxicol |
1996 |
Marek GJ, Aghajanian GK |
LSD and the phenethylamine hallucinogen DOI are potent partial agonist... |
J Pharmacol Exp Ther |
1996 |
Mathews JD, Riley MD, Fej... |
Effects of the heavy usage of kava on physical health: summary of a pi... |
Med J Aust |
1998 |
Donnelly-Roberts DL, Putt... |
ABT-594 [R-5-2-azetidinylmethoxy-2-chloropyridine]: a novel, orally ef... |
J Pharmacol Exp Ther |
1998 |
Westwood SC, Hanson GR |
Effects of stimulants of abuse on extrapyramidal and limbic neuropepti... |
J Pharmacol Exp Ther |
1999 |
Shirayama Y, Hashimoto K,... |
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA i... |
Eur J Pharmacol |
2000 |
Rella JG, Nelson LS, Hoff... |
7 years of 3,4-methylenedioxymethamphetamine (MDMA) toxicity |
Int J Med Toxicol |
2000 |
Robertson P, DeCory HH, M... |
In vitro inhibition and induction of human hepatic cytochrome P450 enz... |
Drug Metab Dispos |
2000 |
Rothman RB, Baumann MH, D... |
Amphetamine-type central nervous system stimulants release norepinephr... |
Synapse |
2001 |
Rajamani K, Leong S, Lave... |
Prejunctional actions of methylenedioxymethamphetamine in vas deferens... |
European Journal of ... |
2001 |
Klonoff-Cohen H, Lam-Krug... |
Maternal and paternal recreational drug use and sudden infant death sy... |
Arch Pediatr Adolesc... |
2001 |
Kosel BW, Aweeka FT, Beno... |
The effects of cannabinoids on the pharmacokinetics of indinavir and n... |
AIDS |
2002 |
Drummer OH, Gerostamoulos... |
The incidence of drugs in drivers killed in Australian road traffic cr... |
Forensic Sci Int |
2003 |
Murray RA, Doering PL, Bo... |
Putting an Ecstasy test kit to the test: harm reduction or harm induct... |
Pharmacotherapy |
2003 |
Turner C, Russell A, Brow... |
Prevalence of illicit drug use in young Australian women, patterns of ... |
Addiction |
2003 |
Henquet C, Krabbendam L, ... |
Prospective cohort study of cannabis use, predisposition for psychosis... |
BMJ |
2005 |
Liechti ME, Kunz I, Kupfe... |
Acute medical problems due to Ecstasy use. Case-series of emergency de... |
Swiss Med Wkly |
2005 |
Furey ML, Drevets WC |
Antidepressant efficacy of the antimuscarinic drug scopolamine: a rand... |
Arch Gen Psychiatry |
2006 |
Braden MR, Parrish JC, Na... |
Molecular interaction of serotonin 5-HT2A receptor residues Phe339(651... |
Mol Pharmacol |
2006 |
Salem EA, Wilson SK, Biss... |
Tramadol HCL has promise in on-demand use to treat premature ejaculati... |
J Sex Med |
2008 |
Zuurman L, Roy C, Schoema... |
Effect of intrapulmonary tetrahydrocannabinol administration in humans |
J Psychopharmacol |
2008 |
Drees JC, Stone JA, Wu AH |
Morbidity involving the hallucinogenic designer amines MDA and 2C-I |
J Forensic Sci |
2009 |
Ng SH, Tse ML, Ng HW, Lau... |
Emergency department presentation of ketamine abusers in Hong Kong: a ... |
Hong Kong Med J |
2010 |
Wood DM, Davies S, Greene... |
Case series of individuals with analytically confirmed acute mephedron... |
Clin Toxicol Phila |
2010 |
Griffiths RR, Johnson MW,... |
Psilocybin occasioned mystical-type experiences: immediate and persist... |
Psychopharmacology (... |
2011 |
Coyle JR, Presti DE, Bagg... |
Quantitative Analysis of Narrative Reports of Psychedelic Drugs |
arXiv.org : Quantita... |
2012 |
Absalom N, Eghorn LF, Vil... |
α4βδ GABAA receptors are high-affinity targets for ^... |
Proc Natl Acad Sci U... |
2012 |
Fantegrossi WE, McCain KR... |
Not simply synthetic tetrahydrocannabinol |
J Pediatr |
2013 |
Smith JP, Metters JP, Irv... |
Forensic electrochemistry: the electroanalytical sensing of synthetic ... |
Analyst |
2014 |
Appendino G, Minassi A, T... |
Recreational drug discovery: natural products as lead structures for t... |
Natural Products Rep... |
2014 |
Castelli R2, Thornton SL,... |
True or False? Analysis of phencyclidine positive urine drug immunoass... |
NAACT Abstract |
2015 |
Coffman C, Trimbath M, Ga... |
Twitter Posts, Gist, and the Perceived Risk of Using a Novel Recreatio... |
National Conference ... |
2015 |
Bakota E, Arndt C, Romose... |
Fatal Intoxication Involving 3-MeO-PCP: A Case Report and Validated Me... |
J Anal Toxicol |
2016 |
Jones MJ, Hernandez BS, J... |
A case of U-47700 overdose with laboratory confirmation and metabolite... |
Clin Toxicol (Phila) |
2016 |
Vrolijk RQ, Brunt TM, Vre... |
Is online information on ecstasy tablet content safe? |
Addiction |
2017 |
Grifell M, Ventura M, Car... |
Patterns of use and toxicity of new para-halogenated substituted cathi... |
Hum Psychopharmacol |
2017 |
Elliott L, Benoit E, Camp... |
The long tail of a demon drug: The 'bath salts' risk environment |
Int J Drug Policy |
2017 |
Ingram R, Kang H, Lightma... |
Some distorted thoughts about ketamine as a psychedelic and a novel hy... |
Neuropharmacology |
2018 |